IO360° Summit

Day Three: Wednesday, March 26, 2025

List/Print View

Grid View

Showing Events in 1 Track from 08:20am to 09:25am

IO Clinical Advancements Plenary

8:20AM - 8:50AM

Registration & 1:1 Partnering Meetings

8:50AM - 9:00AM

Day Three Welcome

9:00AM - 9:25AM

Keynote: Adaptimmune's Pioneering TCR-Based Cell Therapy - Transforming Treatment for Solid Tumors

Keynote Speaker:

Elliot Norry, MD, FACP, CMO, Adaptimmune LLC

Showing Events in 1 Track from 09:25am to 09:45am

IO Clinical Advancements Plenary

9:25AM - 9:45AM

PRAME TCR-Ts for Solid Tumors

Speaker:

Delfi Krishna, PhD, VP, Strategic Operations, Immatics Biotechnologies

Showing Events in 1 Track from 09:45am to 10:25am

Morning IO360º Breakfast, Networking, Exhibits & 1:1 Partnering Meetings

9:45AM - 10:25AM

Morning IO360º Breakfast, Networking, Exhibits & 1:1 Partnering Meetings

Showing Events in 1 Track from 10:25am to 12:00pm

IO Clinical Advancements Plenary (continued)

10:25AM - 11:00AM

Navigating IO Drug Development for Biotechs in a Saturated Field: Insights and Strategies

Moderator:

Priti Hegde, PhD, SVP and Global Head of Research, Kite Pharma, a Gilead Company

Panelists:

Roy Baynes, MD, PhD, EVP & CMO, Eikon Therapeutics

Sharon Benzeno, PhD, MBA, Chief Commercial Officer, Immune Medicine, Adaptive Biotechnologies

Rachel Humphrey, MD, President and Founding CEO, Normunity

Theresa LaVallee, PhD, Chief Development Officer, Coherus BioSciences

11:00AM - 11:20AM

Clinical Updates on CD226

11:20AM - 11:40AM

Neoadjuvant Immunotherapy Clinical Developments in Multiple Tumor Types

Speaker:

Alexander Eggermont, MD, PhD, CSO / Professor, Clinical & Translational Immunotherapy, Princess Máxima Center for Pediatric Oncology / UMC Utrecht, Utrecht University

11:40AM - 12:00PM

Updates on CTLA4 PD1 Combo

Showing Events in 1 Track from 12:15pm to 01:15pm

Lunch

12:15PM - 1:15PM

Lunch on Own & 1:1 Partnering Meetings

Showing Events in 1 Track from 01:15pm to 03:20pm

IO Clinical Advancements Plenary (Continued)

1:15PM - 1:40PM

Afternoon Keynote: CAR-T in Autoimmune Diseases

Speaker:

Prof. Dr. Georg Schett, VP Research FAU and Head of Department of Medicine 3 – Rheumatology and Immunology, Uniklinikum Erlangen and FAU Erlangen-Nürnberg

1:40PM - 2:00PM

Updates on ADC Clinical Developments

Speaker:

Olivier Rixe, MD, PhD, Global Head, Early Clinical Development, Daiichi Sankyo

2:00PM - 2:20PM

Clinical and Translational Learnings During Development of Abecma - The First Approved Myeloma CAR -T Cell Therapy

Speaker:

Timothy Campbell, MD, PhD, VP, Hematology and Cell Therapy, Early Clinical Development, BMS

2:20PM - 2:40PM

CHS-114: A Highly Selective Cytolytic CCR8 Monoclonal Antibody Treatment in HNSCC Patients with and without Toripalimab

Speaker:

Varun Kapoor, PhD, Senior Director, Translational Medicine, Coherus Biosciences

2:40PM - 3:00PM

Solid Tumor CD3 Redirectors

Speaker:

Charles Drake, MD, PhD, VP, Immuno-Oncology, J&J Innovative Medicine

3:00PM - 3:20PM

Expanding RNA Interference Applications to Oncology

Showing Events in 1 Track from 03:40pm to 03:45pm

End of Conference

3:40PM - 3:45PM

End of Conference

Showing Events in 1 Track from 08:20am to 09:25am

IO Clinical Advancements Plenary

8:20AM - 8:50AM

Registration & 1:1 Partnering Meetings

8:50AM - 9:00AM

Day Three Welcome

9:00AM - 9:25AM

Keynote: Adaptimmune's Pioneering TCR-Based Cell Therapy - Transforming Treatment for Solid Tumors

Keynote Speaker:

Elliot Norry, MD, FACP, CMO, Adaptimmune LLC

Showing Events in 1 Track from 09:25am to 09:45am

IO Clinical Advancements Plenary

9:25AM - 9:45AM

PRAME TCR-Ts for Solid Tumors

Speaker:

Delfi Krishna, PhD, VP, Strategic Operations, Immatics Biotechnologies

Showing Events in 1 Track from 09:45am to 10:25am

Morning IO360º Breakfast, Networking, Exhibits & 1:1 Partnering Meetings

9:45AM - 10:25AM

Morning IO360º Breakfast, Networking, Exhibits & 1:1 Partnering Meetings

Showing Events in 1 Track from 10:25am to 12:00pm

IO Clinical Advancements Plenary (continued)

10:25AM - 11:00AM

Navigating IO Drug Development for Biotechs in a Saturated Field: Insights and Strategies

Moderator:

Priti Hegde, PhD, SVP and Global Head of Research, Kite Pharma, a Gilead Company

Panelists:

Roy Baynes, MD, PhD, EVP & CMO, Eikon Therapeutics

Sharon Benzeno, PhD, MBA, Chief Commercial Officer, Immune Medicine, Adaptive Biotechnologies

Rachel Humphrey, MD, President and Founding CEO, Normunity

Theresa LaVallee, PhD, Chief Development Officer, Coherus BioSciences

11:00AM - 11:20AM

Clinical Updates on CD226

11:20AM - 11:40AM

Neoadjuvant Immunotherapy Clinical Developments in Multiple Tumor Types

Speaker:

Alexander Eggermont, MD, PhD, CSO / Professor, Clinical & Translational Immunotherapy, Princess Máxima Center for Pediatric Oncology / UMC Utrecht, Utrecht University

11:40AM - 12:00PM

Updates on CTLA4 PD1 Combo

Showing Events in 1 Track from 12:15pm to 01:15pm

Lunch

12:15PM - 1:15PM

Lunch on Own & 1:1 Partnering Meetings

Showing Events in 1 Track from 01:15pm to 03:20pm

IO Clinical Advancements Plenary (Continued)

1:15PM - 1:40PM

Afternoon Keynote: CAR-T in Autoimmune Diseases

Speaker:

Prof. Dr. Georg Schett, VP Research FAU and Head of Department of Medicine 3 – Rheumatology and Immunology, Uniklinikum Erlangen and FAU Erlangen-Nürnberg

1:40PM - 2:00PM

Updates on ADC Clinical Developments

Speaker:

Olivier Rixe, MD, PhD, Global Head, Early Clinical Development, Daiichi Sankyo

2:00PM - 2:20PM

Clinical and Translational Learnings During Development of Abecma - The First Approved Myeloma CAR -T Cell Therapy

Speaker:

Timothy Campbell, MD, PhD, VP, Hematology and Cell Therapy, Early Clinical Development, BMS

2:20PM - 2:40PM

CHS-114: A Highly Selective Cytolytic CCR8 Monoclonal Antibody Treatment in HNSCC Patients with and without Toripalimab

Speaker:

Varun Kapoor, PhD, Senior Director, Translational Medicine, Coherus Biosciences

2:40PM - 3:00PM

Solid Tumor CD3 Redirectors

Speaker:

Charles Drake, MD, PhD, VP, Immuno-Oncology, J&J Innovative Medicine

3:00PM - 3:20PM

Expanding RNA Interference Applications to Oncology

Showing Events in 1 Track from 03:40pm to 03:45pm

End of Conference

3:40PM - 3:45PM

End of Conference

Day Two

Tuesday, March 25, 2025

Day Three

Wednesday, March 26, 2025

Day Two

Day Three

Subscribe for More Information